Mount Sinai Heart's Valentín Fuster, MD, Discusses the "Polypill" at the European Society of Cardiologists (ESC) Congress 2022

Join Director of Mount Sinai Heart, Valentín Fuster, MD, PhD, MACCas he discusses the Polypill and the SECURE trial, of which he is the chief investigator, at the European Society of Cardiology (ESC) Congress 2022.

The three-drug medication known as a “polypill” was found effective in preventing adverse events such as heart attacks or stroke in people who have previously had a heart attack, reducing cardiovascular mortality by 33 percent in this patient population.

Here Dr. Fuster discusses findings with Louise Bowman from the University of Oxford ESC 2022 in Barcelona.

Related Presenters

Valentin Fuster, MD, PhD.

Valentin Fuster, MD, PhD

Director, The Zena and Michael Wiener Cardiovascular Institute
Icahn School of Medicine at Mount Sinai
Director, Mount Sinai Heart
The Mount Sinai Hospital

View full profile